IRIS
DELLA TORRE, EMANUEL
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.042
AS - Asia 4.431
NA - Nord America 3.743
SA - Sud America 1.152
Continente sconosciuto - Info sul continente non disponibili 280
AF - Africa 98
OC - Oceania 40
Totale 14.786
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.531
RU - Federazione Russa 2.520
CN - Cina 1.463
SG - Singapore 1.463
IT - Italia 1.117
BR - Brasile 929
HK - Hong Kong 529
SE - Svezia 517
VN - Vietnam 434
FR - Francia 216
DE - Germania 167
BD - Bangladesh 161
GB - Regno Unito 135
FI - Finlandia 94
CA - Canada 92
AR - Argentina 76
IN - India 72
MX - Messico 61
NL - Olanda 58
ID - Indonesia 42
ES - Italia 40
JP - Giappone 40
TR - Turchia 38
AT - Austria 37
PL - Polonia 37
ZA - Sudafrica 35
AU - Australia 33
CO - Colombia 32
IQ - Iraq 32
EC - Ecuador 31
PY - Paraguay 25
PK - Pakistan 22
IE - Irlanda 19
UA - Ucraina 19
VE - Venezuela 18
CL - Cile 16
MY - Malesia 16
PE - Perù 16
MA - Marocco 14
EG - Egitto 13
PH - Filippine 13
CR - Costa Rica 11
JM - Giamaica 11
SA - Arabia Saudita 11
TN - Tunisia 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
IL - Israele 10
IR - Iran 10
KE - Kenya 10
BE - Belgio 9
CH - Svizzera 9
HN - Honduras 9
JO - Giordania 9
LT - Lituania 9
NP - Nepal 7
NZ - Nuova Zelanda 7
DO - Repubblica Dominicana 6
DZ - Algeria 6
GT - Guatemala 6
HU - Ungheria 6
KZ - Kazakistan 5
NI - Nicaragua 5
RO - Romania 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
AL - Albania 4
CY - Cipro 4
KR - Corea 4
LB - Libano 4
LV - Lettonia 4
PT - Portogallo 4
BH - Bahrain 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
GR - Grecia 3
MD - Moldavia 3
SV - El Salvador 3
TW - Taiwan 3
AZ - Azerbaigian 2
CG - Congo 2
DM - Dominica 2
EU - Europa 2
HR - Croazia 2
SC - Seychelles 2
AM - Armenia 1
BG - Bulgaria 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BW - Botswana 1
BY - Bielorussia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
Totale 14.502
Salva come PNG Salva come JPEG
Città #
Singapore 624
Moscow 526
Hong Kong 524
Dallas 460
San Jose 443
Ashburn 379
Shanghai 326
Beijing 279
Council Bluffs 215
Milan 203
Hefei 199
New York 195
Lawrence 183
Princeton 183
Lauterbourg 179
Ho Chi Minh City 154
Phoenix 117
Rome 100
Hanoi 95
Los Angeles 89
São Paulo 89
Santa Clara 83
Helsinki 78
Boardman 52
Munich 45
Rio de Janeiro 35
Orem 33
Denver 32
Nuremberg 32
Warsaw 32
London 31
Montreal 26
Tokyo 26
Seattle 25
Belo Horizonte 24
Brooklyn 24
Turin 24
Atlanta 23
Bologna 23
Toronto 23
Guangzhou 22
Mexico City 22
Poplar 21
Frankfurt am Main 20
Naples 20
Dublin 19
Chennai 18
Florence 18
Boston 17
Cagliari 17
Houston 17
Da Nang 16
Haiphong 16
Vienna 16
Genoa 15
Stockholm 15
Baghdad 14
Brasília 14
Cesano Boscone 14
Johannesburg 14
Ankara 13
Manaus 13
Amsterdam 12
Bari 12
Mapello 12
Quito 12
Bogotá 11
Chicago 11
Figino 11
Kuala Lumpur 11
Pescara 11
Porto Alegre 11
San Francisco 11
Turku 11
Verona 11
Biên Hòa 10
Curitiba 10
Guarulhos 10
Nairobi 10
Pavia 10
Rovigo 10
Tashkent 10
Wollongong 10
Xi'an 10
Asunción 9
Bergamo 9
Buffalo 9
Cape Town 9
Galliate 9
Guayaquil 9
Jakarta 9
Jiaxing 9
Melbourne 9
Mumbai 9
Pune 9
Salvador 9
Amman 8
Barnet 8
Basingstoke 8
Brescia 8
Totale 6.981
Salva come PNG Salva come JPEG
Nome #
Outcomes of non-invasive ventilation as the ceiling of treatment in patients with COVID-19 402
PACHIMENINGITE IPERTROFICA IGG4-CORRELATA: DIAGNOSI E RISPOSTA TERAPEUTICA 380
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 213
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 182
IgG4-Related Midline Destructive Lesion: Expanding the spectrum of organ involvement in IgG4-related disease 178
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 177
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients 166
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 157
ABS0671 IgG4-RELATED DISEASE IN OVERLAP WITH IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: CLINICAL-PATHOLOGICAL CHARACTERISTICS AND THERAPEUTIC IMPLICATIONS OF AN ORPHAN DISEASE 156
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 148
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 138
Dupilumab as a potential steroid-sparing treatment for IgG4-related disease. 135
A cd8 alpha-negative subset of cd4+slamf7+ cytotoxic t cells is expanded in patients with igg4-related disease and decreases following glucocorticoid treatment 132
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 131
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 122
Urgent manifestations of immunoglobulin G4-related disease 120
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma 116
ASSOCIAZIONE TRA MALATTIA IGG4-CORRELATA E IMMUNOTERAPIA ALLERGENE-SPECIFICA. STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO. 116
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 114
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 113
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 111
Advances in the diagnosis and management of IgG4 related disease. 110
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 109
Analisi delle sottopopolazioni T linfocitarie su sangue periferico dei pazienti affetti da malattia IgG4 correlata: aspetti patogenetici e risposta alla terapia con rituximab 109
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study 107
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 104
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 103
IgG4-related pachymeningitis: evidence of intrathecal IgG4 on cerebrospinal fluid analysis. 102
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 101
CLINICAL PHENOTYPES OF IGG4- RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL FEATURES, SEROLOGICAL FINDINGS,AND PROGNOSTIC OUTCOMES 101
Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature. 99
Are atopy and eosinophilic bronchial inflammation associated with relapsing forms of chronic rhinosinusitis with nasal polyps? 98
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 98
A unique case of IgG4-related pachymeningitis treated with intrathecal rituximab 98
ANTIAPOPTOTIC AND IMMUNOMODULATORY EFFECTS OF INTERLEUKIN 7 IN AN EX VIVO MODEL OF HUMAN LYMPHOID TISSUE 98
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 96
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: A European multi-centre study 94
ALLERGIC PROFILE AND ALLERGENSPECIFIC IMMUNOTHERAPY IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A SINGLE CENTER OBSERVATIONAL STUDY 94
CIRCULATING PLASMABLASTS LEVELS REFLECT INFLAMMATORY ACTIVITY IN IGG4-RELATED DISEASE LESIONS AS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY 93
Clinical and dermoscopic features of Castelman's disease: insights from an emblematic case 93
Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort' 92
Effects Of Glucocorticoids On B Cell Subpopulations In Patients With IgG4-Related type I autoimmune pancreatitis 92
"How I manage" IgG4-Related Disease 92
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. 91
CLINICAL MANIFESTATIONS OF IGG4-RELATED DISEASE ONSET REQUIRE ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES. EXPERIENCE FROM A SINGLE ITALIAN REFERRAL CENTRE 90
Lymphadenopathy in the rheumatology practice: a pragmatic approach 89
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE 89
EFFECTS OF GLUCOCORTICOIDS AND METHOTREXATE-BASED THERAPEUTIC REGIMENS ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 88
Atypical presentation of Churg-Strauss syndrome or an undescribed hypereosinophilic disease? 87
B cells orchestrate tissue fibrosis in IgG4-Related Disease 87
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease 86
IDENTIFICAZIONE DI UNA SOTTOPOPOLAZIONE CD8- DI LINFOCITI CD4 CITOTOSSICI ESPANSA NEI PAZIENTI CON MALATTIA IGG4-CORRELATA E RESPONSIVA ALLA TERAPIA CON GLUCOCORTICOIDI 86
IMMUNOTERAPIA SPECIFICA E MALATTIA IgG4-CORRELATA: STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO 86
INFLAMMATORY ACTIVITY OF IgG4-RELATED DISEASE LESIONS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY CORRELATES WITH CIRCULATING PLASMABLASTS LEVELS 85
EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case-control study 84
Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis 84
25. Epinephrine autoinjector prescription in food-allergic adults: symptom-based only or allergen-based also? An Italian multi-centre study. 83
Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers. 82
Salivary Gland Disease in IgG4-Related Disease is Associated with Allergic Conditions 82
An International, Multi-Specialty Validation Study of the IgG4-Related Disease Responder Index 82
CLINICAL PHENOTYPES OF IGG4-RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL, IMMUNOLOGICAL AND PROGNOSTIC FEATURES 80
Artrite reumatoide. Dottore mi spieghi meglio 80
Atopia e malattia IgG4-correlata: relazione casuale o causale? 80
Efficacy of Siltuximab and 1,927 nm Fractional Laser for the Treatment of Cutaneous Manifestations in Castleman's Disease: The Role of Dermoscopy and Reflectance Confocal Microscopy for Lesion Evaluation 78
IGG4 RELATED HYPERTROPHIC PACHYMENINGITIS: DIAGNOSTIC APPROACH AND THERAPEUTIC OUTCOMES 78
MAVRILIMUMAB IMPROVES OUTCOMES IN SEVERE COVID-19 PNEUMONIA AND SYSTEMIC HYPERINFLAMMATION 77
Methotrexate as induction of remission therapy for localized manifestations of IgG4-Related Disease. 77
EFFICACY OF LONG-TERM TREATMENT WITH BIOLOGIC AGENTS IN REFRACTORY ADULT ONSET STILL’S DISEASE: A SINGLE CENTRE EXPERIENCE ON 16 PATIENTS 77
Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli 73
Systemic lupus erythematosus and COVID-19: what we know so far 73
IgG4-RELATED DISEASE PRESENTATION REQUIRES ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES 73
LONG-TERM EFFICACY OF RITUXIMAB MAINTENANCE THERAPY FOR IGG4- RELATED DISEASE RITUXIMAB MAINTENANCE THERAPY IN IGG4-RELATED DISEASE 72
IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. 72
Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to: 'Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al ' by Cheng and Zhang 71
CLONAL EXPANSION OF CD4+ CYTOTOXIC T LYMPHOCYTES IN IGG4-RELATED DISEASE 71
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED AUTOIMMUNE PANCREATITIS 71
METHOTREXATE AS INDUCTION OF REMISSION THERAPY FOR LOCALIZED MANIFESTATIONS OF IGG4-RELATED DISEASE 70
MALATTIA IGG4-CORRELATA: ESPERIENZA QUINQUENNALE MONOCENTRICA SU UNA CORTE ITALIANA DI 150 PAZIENTI (2013 - 2018) 70
EpidemAAITO: features of food allergy in Italian adults attending allergy clinics: a multi-centre study 69
INCREASE OF CIRCULATING MEMORY B CELLS AFTER GLUCOCORTICOID-INDUCED REMISSION PREDICTS IGG4-RELATED DISEASE RELAPSE 68
Immunomodulatory Effects of Endoscopic Ultrasound-Guided Thermal Ablation in Patients with Pancreatic Ductal Adenocarcinoma 67
Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis 67
HYPERSENSITIVITY REACTIONS TO LOW MOLECULAR WEIGHT HEPARIN IN A PREGNANT WOMAN 66
In vivo tests with "Tahini" sauce: new allergenic source to evaluate IgE-mediated hypersensitivity to sesame. 66
CD4+ and CD8+ cytotoxic T lymphocytes may induce mesenchymal cell apoptosis in IgG4-related disease. 66
Palate perforation differentiates cocaine-induced midline destructive lesions from granulomatosis with polyangiitis 65
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circula-ting plasmablasts in IgG4-related type 1 au-toimmune pancreatitis and other organs 65
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE 65
Malattia sistemica e colangiopatia IgG4-relata 65
EFFETTI DEL PREDNISONE SULLE SOTTOPOPOLAZIONI B LINFOCITARIE NEI PAZIENTI CON MALATTIA IgG4-CORRELATA 64
IgG4-Related diseases 64
Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse 63
Immunology of IgG4-related disease 62
EFFECTS OF COMBINED THERAPY WITH PREDNISONE AND METHOTREXATE ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 62
MERTK AND THE RESOLUTION OF INFLAMMATION IN IGG4-RELATED DISEASE 62
EFFECTS OF COMBINED THERAPY WITH PREDNISONE AND METHOTREXATE ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 62
Side effects from polydioxanone 62
B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. 62
Malattie autoinfiammatorie e altre malattie immunomediate a patogenesi incerta 62
IgG4-related autoimmune liver disease 61
Totale 9.909
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.209
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.209
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022347 0 0 151 33 6 22 14 23 34 21 23 20
2022/20231.129 455 213 66 8 32 115 62 57 59 14 22 26
2023/2024920 30 62 81 82 49 167 42 89 5 42 92 179
2024/20252.858 351 84 81 76 97 222 352 300 550 329 177 239
2025/20268.382 631 790 689 1.061 631 258 680 560 2.181 446 261 194
2026/20271.100 356 577 167 0 0 0 0 0 0 0 0 0
Totale 14.786